Claudin18.2 as a potential therapeutic target for primary ovarian mucinous carcinomas and metastatic ovarian mucinous carcinomas from upper gastrointestinal primary tumours

BACKGROUND: The vast majority of ovarian mucinous carcinomas are metastatic tumours derived from nonovarian primary cancers, typically gastrointestinal neoplasms. Therapy targeting claudin18.2 might be used in gastric, gastroesophageal junction and pancreatic cancers with high expression of claudin1...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Fujun, Yang, Yao, Du, Xiuzhen, Zhu, Xiaoying, Hu, Yanjiao, Lu, Changyu, Sui, Lei, Zhao, Han, Song, Kejuan, Yao, Qin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9837907/
https://www.ncbi.nlm.nih.gov/pubmed/36639622
http://dx.doi.org/10.1186/s12885-023-10533-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9837907/
https://www.ncbi.nlm.nih.gov/pubmed/36639622
http://dx.doi.org/10.1186/s12885-023-10533-x

Ejemplares similares